Add Company
Join Now

Belite Bio Revenue and Competitors

License our Company Data API

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Belite Bio's estimated annual revenue is currently $3.6M per year.(i)
  • Belite Bio's estimated revenue per employee is $155,000

Employee Data

  • Belite Bio has 23 Employees.(i)
  • Belite Bio grew their employee count by 28% last year.

Belite Bio's People

NameTitleEmail/Phone
1
Chairman and CEOReveal Email/Phone
2
Co-FounderReveal Email/Phone
3
VP Clinical OperationsReveal Email/Phone
4
Head Regulatory AffairsReveal Email/Phone
5
Senior Director CMCReveal Email/Phone
6
Clinical Project ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.4M70-8%$53MN/A
#2
$32.4M167-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.8M1813%N/AN/A
#5
$0.8M5-50%N/AN/A
#6
$0.8M100%N/AN/A
#7
$14M90-12%N/AN/A
#8
$0.4M33610%$236.7MN/A
#9
$4.8M62-74%$160MN/A
#10
$3.7M24-8%N/AN/A
Add Company

What Is Belite Bio?

Belite Bio Inc is a San Diego based clinical stage biopharmaceutical drug development company targeting untreatable age-related metabolic diseases, including macular degeneration, liver disease and diabetes. Developed from our anti-RBP4 technology platform, our lead candidate, LBS-008, is currently in a Phase I clinical trial for dry age-related macular degeneration and its juvenile form, Stargardt disease. LBS-008 has received Orphan Drug Status in the US and Europe, as well as Rare Pediatric Disease Status in the US.

keywords:N/A

N/A

Total Funding

23

Number of Employees

$3.6M

Revenue (est)

28%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$2.3M23N/AN/A
#2
$2.3M23N/AN/A
#3
$3.4M23-68%N/A
#4
$3.3M23-8%N/A
#5
$2.4M2315%N/A